Empirical Drug Therapy for Idiopathic Male Infertility: What is the New Evidence?

Urology. 2015 Dec;86(6):1065-75. doi: 10.1016/j.urology.2015.07.030. Epub 2015 Aug 5.

Abstract

Idiopathic male infertility is empirically managed using a number of drugs. We reviewed 64 articles published in the last 10 years on such drug therapy. There was severe heterogeneity in data along with poor definition of outcome parameters. Pregnancy or live birth rate was not reported in many studies. Antiestrogens appear to improve pregnancy rates while there is some data supporting the use of aromatase inhibitors. Antioxidants significantly increase the rate of both live birth and pregnancy but the data are limited. However, valid end-points based on data are limited for the empirical use of drugs in idiopathic male infertility.

Publication types

  • Review

MeSH terms

  • Antioxidants / therapeutic use*
  • Arginine / therapeutic use
  • Aromatase Inhibitors / therapeutic use
  • Carnitine / therapeutic use
  • Carotenoids / therapeutic use
  • Estrogen Receptor Modulators / therapeutic use
  • Female
  • Glutathione / therapeutic use
  • Gonadotropins / therapeutic use
  • Humans
  • Infertility, Male / drug therapy*
  • Live Birth*
  • Lycopene
  • Male
  • Pregnancy
  • Pregnancy Rate*
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / therapeutic use
  • Vitamin E / therapeutic use

Substances

  • Antioxidants
  • Aromatase Inhibitors
  • Estrogen Receptor Modulators
  • Gonadotropins
  • Ubiquinone
  • Vitamin E
  • Carotenoids
  • Arginine
  • coenzyme Q10
  • Glutathione
  • Carnitine
  • Lycopene